All Transactions - Bryan, Garnier & Co

Our transactions

Bryan, Garnier & Co offers a complete range of investment banking services, from growth financing to mergers and acquisitions.

Bryan, Garnier & Co acts as Sole Financial Advisor to the Shareholders of Groupe Artemys, IT services specialist, on its acquisition of AJS Formation

Bryan, Garnier & Co acted as sole financial advisor to Mailinblack and its shareholders on the LBO led by Apax Partners alongside New Alpha Verto, management and historical shareholders

Bryan, Garnier & Co acted as Sole Financial Advisor to New Alpha Verto on its investment in GAC Technology

Bryan, Garnier & Co acts as Sole Global Coordinator and Joint Bookrunner on Abivax’s EUR 49 million Cross-over Financing

Bryan, Garnier & Co acts as Sole Financial Advisor to the shareholders, Altana AG and Hans Mathea, founder and CEO of dp polar GmbH, a leading developer and producer of 3D printing systems for industrial series production on the contemplated sale of the Company to NYSE-listed 3D Systems

Bryan, Garnier & Co acts as Sole Financial Advisor to Ganymed Robotics, a developer of computer vision software and robotics technologies for orthopedic surgeons, on its first €21 million closing of its oversubscribed Fundraising

Bryan, Garnier & Co acts as Sole Financial Advisor to Oncodesign on the sale of its CRO activities to Elyan Partners for €100m and the concomitant spin-off of its Biotech/AI activities

Bryan, Garnier & Co acted as Sole Financial Advisor to Vade and its shareholders on its €28m fundraising from Tikehau Ace Capital, Bpifrance and Auriga Partners

Bryan, Garnier & Co acts as Sole Financial Advisor to the Management of Astrocast, leading global IoT satellite operator, on its contemplated acquisition of Hiber

Bryan, Garnier & Co acts as Sole Financial Advisor to Laurent Blanc and Phillimore, shareholders of the design and lifestyle media group Ideat Editions, on its contemplated sale to I/O Media

Bryan, Garnier & Co acts as Sole Financial Advisor to Enapter AG on a €20m strategic investment from Johnson Matthey

Bryan, Garnier & Co acts as Sole Financial Advisor to Bridgepoint Development Capital on their contemplated investment in CAST

Bryan, Garnier & Co acts as Sole Global Coordinator & Sole Bookrunner on GeNeuro EUR 7.7 million Follow-On Offering

Bryan, Garnier & Co acts as Sole Financial Advisor to the Sellers of Våning 18 to Äleven

Bryan, Garnier & Co acts as Sole Financial Advisor to the shareholders of Grundium Oy on the sale of a majority stake to EW Healthcare Partners

Bryan, Garnier & Co advises Qualium Investissement on its acquisition of Recocash from IK Partners

Bryan, Garnier & Co acts as Sole Financial Advisor to Capza and the Management of Horizon Software, leading electronic trading software provider, on the contemplated sale of the Company to Sagard NewGen

Bryan, Garnier & Co acts as Joint Global Coordinator and Joint Bookrunner on Avantium’s Euronext Amsterdam EUR 45m Publicly Marketed Follow-On Offering

Bryan, Garnier & Co acts as Sole Financial Advisor to Protix on its €50 million Fundraising

Bryan, Garnier & Co advises Cathay Capital, Sagard NewGen and Eurazeo on their investment in DiliTrust

Bryan, Garnier & Co acts as Sole Financial Advisor and Sole Placement Agent to the leading geo-analytics company Kayrros on its €40 million Series C financing from New Space Capital, Bpifrance, Opera Tech Ventures (BNP Paribas VC arm), EIB and existing shareholders

Bryan, Garnier & Co acts as Sole Financial Advisor to Praxedo and its founders on a growth LBO led by MBO & Co

Bryan, Garnier & Co acts as Exclusive Financial Advisor to the shareholders and founders of kompany on the sale of the company to Moody’s

Bryan, Garnier & Co acts as Sole Financial Advisor to Sword Group SE on the disposal of Sword GRC to Riskonnect, a portfolio company of TA Associates

Bryan, Garnier & Co acts as Joint Global Coordinator and Joint Bookrunner on Aelis Farma’s Euronext Paris EUR 25m Initial Public Offering

Bryan, Garnier & Co acts as Sole Financial Advisor to clinical-stage biologics company BiosanaPharma on its global strategic partnership with Alvotech

Bryan, Garnier & Co acts as Sole Financial Advisor to Padoa and its shareholders on the investment of Five Arrows Growth Capital

Bryan, Garnier & Co acted as Sole Financial Advisor to the shareholders of CyberCité, a SEO and SEA agency, on the sale of the Company to Isoskele, part of Groupe La Poste

Bryan, Garnier & Co acts as Sole Financial Advisor to MNH on the sale of AKLIA to Hoppen

Bryan, Garnier & Co is proud to act as Joint Bookrunner to Cell Impact on its SEK 349m Rights Issue

Bryan, Garnier & Co acts as Sole Financial Advisor to Wandercraft on its $45 million Fundraising

Bryan, Garnier & Co acted as Sole Financial Advisor to the shareholders of CMN on its partnership with MBO & Co

Bryan, Garnier & Co acts as Sole Financial Advisor to the shareholders of Headwall Photonics on the sale of the company to Arsenal Capital Partners

Bryan, Garnier & Co acts as Joint Global Coordinator and Joint Bookrunner to Nicox on its EUR 15 million Follow-on Offering of shares and warrants

Bryan, Garnier & Co acts as Sole Financial Advisor to Aquiline Capital Partners and Elyan Partners on their potential investment in Cheops Technology

Bryan, Garnier & Co acts as Sole Financial Advisor to the sellers of Human Performance to Äleven

Bryan, Garnier & Co acts as Sole Financial Advisor, Sole Global Coordinator and Sole Bookrunner to leading global IoT satellite operator Astrocast on its private placement and subsequent direct listing on Euronext Growth, securing a total of CHF 45 million for the company

Bryan, Garnier & Co acts as Sole Financial Advisor to Quilvest Capital Partners and the Management of Eudonet, a European vertical CRM software provider, on the sale of the Company to Montagu Private Equity

Bryan, Garnier & Co acts as Sole Financial Advisor to the shareholders and founders of Evora IT Solutions Group on the sale of the company to Allgeier SE

Bryan, Garnier & Co acts as Sole Financial Advisor to EasyVista on its acquisition of ServiceNav by Coservit

Bryan, Garnier & Co acts as Sole Financial Advisor to the shareholders of Elmatica in the sale of the company to NCAB Group AB

Bryan, Garnier & Co acts as Sole Global Coordinator and Sole Bookrunner on BALYO’s EUR 7.8 million Follow-on Offering

Bryan, Garnier & Co acts as Sole Financial Advisor to Parquest Capital on its minority investment in Advens

Bryan, Garnier & Co acts as Sole Financial Advisor to the shareholders of Kea & Partners on the minority investment by Crédit Mutuel Equity and the debt operations conducted by LCL and Banque Palatine

Bryan, Garnier & Co acts as Sole Financial Advisor to Orfite and BNP Paribas Développement on the sale of Groupe GSCM to Equistone Partners Europe and BNP Paribas Développement reinvestment

Bryan, Garnier & Co acts as Sole Financial Advisor to the shareholders of CanPharma GmbH on the sale of the company to Health House International Ltd (ASX:HHI)

Bryan, Garnier & Co acts as Sole Financial Advisor to TVH Consulting and its shareholders on its secondary LBO with 21 Invest

Bryan, Garnier & Co acts as Sole Financial Advisor to Qred on its Private Placement pursued by Nordic Capital

Bryan, Garnier & Co acts as Sole Financial Advisor to EasyVista on its acquisition of Goverlan, Inc and its financing by Blackrock

Bryan, Garnier & Co acts as Sole Financial Advisor to FCDE on its acquisition of a majority stake in Didactic alongside its management team

Bryan, Garnier & Co acts as Joint Global Coordinator and Joint Bookrunner on Abivax’s EUR 85 million Follow-on Offering & Convertible Bonds Issuance

Bryan, Garnier & Co acts as Sole Financial Advisor to French telemedicine leader Qare on its acquisition by European digital health provider HealthHero